Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Aptevo Therapeutics (APVO) Long-Term Debt Repayments (2020 - 2023)

Aptevo Therapeutics (APVO) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $3.5 million as the latest value for Q1 2023.

  • Quarterly Long-Term Debt Repayments fell 67.8% to $3.5 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Dec 2023, down 71.74% year-over-year, with the annual reading at $3.5 million for FY2023, 71.74% down from the prior year.
  • Long-Term Debt Repayments hit $3.5 million in Q1 2023 for Aptevo Therapeutics, up from $500000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $22.1 million in Q1 2020 to a low of $500000.0 in Q2 2022.
  • Historically, Long-Term Debt Repayments has averaged $6.0 million across 4 years, with a median of $4.2 million in 2021.
  • Biggest YoY gain for Long-Term Debt Repayments was 115.34% in 2022; the steepest drop was 90.99% in 2022.
  • Year by year, Long-Term Debt Repayments stood at $22.1 million in 2020, then tumbled by 74.89% to $5.6 million in 2021, then tumbled by 90.99% to $500000.0 in 2022, then surged by 593.4% to $3.5 million in 2023.
  • Business Quant data shows Long-Term Debt Repayments for APVO at $3.5 million in Q1 2023, $500000.0 in Q4 2022, and $500000.0 in Q3 2022.